Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Medtronic beats Q4 estimates, shows highest revenue growth in 10 years, and trades at 24% discount to fair value.
MDT
$80.48
+$0.01 +0.01%

Medtronic beats Q4 estimates, shows highest revenue growth in 10 years, and trades at 24% discount to fair value.

Analyst Insights
08 Jun 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Medtronic plc exceeded analyst expectations for revenue and non-GAAP EPS in Q4 2026, achieving its highest annual revenue growth in a decade. The company holds a strong A credit rating from S&P with a stable outlook. Despite this, Medtronic's stock is trading at a 24% discount to its estimated fair value, suggesting potential for a 32% total return by the end of fiscal year 2027 and 13% annual returns through 2032. This positions Medtronic as a promising dividend growth stock with potential for reaccelerated dividend growth in the next 1-2 years.

More News (MDT)

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...

Market News
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App